Skip to main content
OpenTrials
Completed

NCT Number: NCT02786004

Image Quality Assessment for Screening and Diagnostic Mammography

This study is being conducted to determine the image quality of images using a new investigational medical imaging device.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Carolina Breast Imaging Specialist

Greenville, North Carolina, 27834, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are women aged 40 years or older (≥40 years old);
  • Have had a FFDM (Full Field Digital Mammography) or DBT (Digital Breast Tomosynthesis) breast imaging exam within 30 days prior to enrollment;
  • Have breast sizes compatible with the dimensions of a 24x29 cm image detector without anatomical cut-off;
  • Are able to walk without assistive devices;
  • Are sterile; post-menopausal; or if of childbearing potential, have a negative pregnancy test or is willing to provide urine sample to confirm no pregnancy, within 30 days of imaging exam; and
  • Are willing to provide written informed consent to participate.

Exclusion criteria

  • Have been previously included in this study or are participating in another trial expected to interfere with study procedures or outcomes;
  • Have a history of breast biopsy, lumpectomy or mastectomy, or reconstruction on either breast;
  • Are currently lactating;
  • Are currently undergoing radiotherapy or chemotherapy , or have a history of prior radiotherapy treatment on either breast; or
  • If enrolled to the DBT (Digital Breast Tomosynthesis) cohort, have breast implants (breast implants are not exclusionary in the FFDM (Full Field Digital Mammography) cohort).

Treatment and study plan

Full Field Digital Mammography

Device

Other names: 2D Mammography

Digital Breast Tomosynthesis

Device

Other names: DBT

Primary outcomes

  1. Number of Participants With Acceptable Overall Clinical Image Quality

    Time frame: At enrollment completion approximately 3 months post initiation

    Overall clinical image quality was assessed by Mammography Quality Standards Act (MQSA) qualified radiologists ("readers"). Readers documented acceptability of FFDM and DBT image quality and image characteristics, as set for in the Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Full Field Digital Mammography System (2012).

Secondary outcomes

  1. Number of Subjects Experiencing a Device Related Adverse Events, Serious Adverse Event, Unanticipated Device Effect, and Device Defects by Overall Occurrence.

    Time frame: Through study completion, approximately 3 months

    Safety-related endpoint data (adverse events, serious adverse event, unanticipated device effect, and device defects) were monitored from all subjects for the duration of their participation. Results were summarized by cohort.

Sponsors and collaborators

Lead sponsor

GE Healthcare

Industry

Registry information

Official study title

Mammography Image Quality Assessment Reading NextGen Images for Screening and Diagnostic Use (MAGNIFI)

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
May 30, 2016
Registry last updated
Nov 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.